[Federal Register Volume 76, Number 53 (Friday, March 18, 2011)]
[Notices]
[Page 14979]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-6453]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Muscular Dystrophy Coordinating Committee (MDCC).
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should inform the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: April 20, 2011.
    Time: 8 a.m. to 4:30 p.m.
    Agenda: The 2011 meeting of the MDCC will review Federal agency 
activities in the muscular dystrophies, brief participants on the 
NIH grant database, NIH RePORTER, discuss therapy development 
resources at the NIH, and review joint NIH/FDA activities and 
initiatives in rare diseases. The MDCC will also discuss new 
opportunities in therapy development based upon a representative 
example of a new mechanistic finding and the lessons learned in 
current drug development programs. A panel will review and discuss 
the challenges of conducting clinical trials in the muscular 
dystrophies.
    An agenda will be posted prior to the meeting on the MDCC Web 
site: http://www.ninds.nih.gov/find_people/groups/mdcc/index.htm.
    Place: Hilton Rockville Hotel & Executive Meeting Center, 1750 
Rockville Pike, Rockville, Maryland 20852-1699.
    Contact Person: John D. Porter, PhD, Executive Secretary, 
Muscular Dystrophy Coordinating Committee, National Institute of 
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, 
NSC 2172, Bethesda, MD 20892, (301) 496-5739, 
[email protected].
    Any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: March 11, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-6453 Filed 3-17-11; 8:45 am]
BILLING CODE 4140-01-P